Virtus NFJ Dividend Value R6 holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Virtus NFJ Dividend Value Fund Class R6 ANDVX
- NAV / 1-Day Return 11.90 / +1.02 %
- Total Assets 525.8M
-
Adj. Expense Ratio
0.650%
- Expense Ratio 0.650%
- Distribution Fee Level Above Average
- Share Class Type Retirement, Large
- Category Large Value
- Investment Style Mid Value
- Min. Initial Investment 3M
- Status Open
- TTM Yield 1.95%
- Turnover 36%
USD | NAV as of Jun 13, 2026 | 1-Day Return as of Jun 13, 2026, 12:07 AM GMT+0
Morningstar’s Analysis ANDVX
Will ANDVX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the ANDVX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of ANDVX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 33.0
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Alphabet Inc Class A | 4.48 | 23M | Communication Services |
Charles Schwab Corp | 4.11 | 21M | Financial Services |
HF Sinclair Corp | 3.91 | 20M | Energy |
Prologis Inc | 3.78 | 19M | Real Estate |
NextEra Energy Inc | 3.03 | 15M | Utilities |
Marvell Technology Inc | 2.99 | 15M | Technology |
The Hershey Co | 2.87 | 15M | Consumer Defensive |
GE Vernova Inc | 2.79 | 14M | Industrials |
Eli Lilly and Co | 2.53 | 13M | Healthcare |
Pfizer Inc | 2.49 | 13M | Healthcare |
United States